Shanghai HyaMab Biotech Co.,Ltd.
Shanghai HyaMab Biotech Co.,Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor | Locally Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2023-12-15 | NCT05801237 | |
| A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor | Advanced Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2023-09-07 | NCT06026501 |